OverviewChartProfileKey statisticsFinancialsTechnicalNews
Derivatives
TraderScreen

Tyler Technologies Corp/  US9022521051  /

NYSE
15/05/2024  19:54:18 Chg. +6.53 Volume Bid20:13:43 Ask20:13:43 Market Capitalization Dividend Y. P/E Ratio
491.38USD +1.35% 78,168
Turnover: 15.93 mill.		 491.18Bid Size: 400 492.05Ask Size: 200 20.86 bill.USD - 124.39
GlobeNewswire 18:17 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 14/05 Freshworks to Participate in Upcoming Investor Conferences
GlobeNewswire 13/05 Digital Journal sets sights on becoming Canada’s premier thought leadership platform with launch of ...
GlobeNewswire 10/05 CannaCon West Coming to the Albuquerque Convention Center in May 2024
GlobeNewswire 09/05 Southside Bancshares, Inc. Declares Cash Dividend
GlobeNewswire 09/05 FOX Factory Performance Vehicle Development Introduces the All-New Black Widow Limited Chevrolet Sil...
GlobeNewswire 09/05 ACELYRIN, INC. Provides Business Update and Highlights Key Upcoming Milestones
GlobeNewswire 09/05 ACELYRIN, INC. Announces Leadership Transition
GlobeNewswire 09/05 VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08/05 Candor Expedite Unveils Pioneering Technology for the Food Industry
GlobeNewswire 08/05 CAULIPOWER, The Better-For-You Brand Reinventing America’s Favorite Comfort Foods, Announces Veteran...
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07/05 Hey Boo Boo! Three New Yogi Bear’s Jellystone Park Locations are Opening this Summer
GlobeNewswire 07/05 Lightbend Adds Industry Veteran Dan Rosanova as Head Of Product
GlobeNewswire 06/05 Cribl Joins Wiz Integration Program to Strengthen Security Posture with Data-Driven Insights
GlobeNewswire 06/05 VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET I...
GlobeNewswire 02/05 Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for Th...
GlobeNewswire 02/05 WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Pow...
GlobeNewswire 01/05 Cipher Mining Announces April 2024 Operational Update
GlobeNewswire 01/05 Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing th...
GlobeNewswire 01/05 Redwood Logistics and American Tire Distributors to Display 4PL Orchestration at Gartner Supply Chai...
GlobeNewswire 01/05 Westwood Announces Launch of Westwood Salient Enhanced Energy Income ETF (WEEI)
GlobeNewswire 01/05 Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to D...
GlobeNewswire 01/05 Goodness Growth Provides CREAM & Fire Updates